Skip to main content

Published locations for Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19

User login

  • Reset your password
  • /content/study-immune-checkpoint-inhibitors-dont-increase-risk-death-cancer-patients-covid-19
  • /edermatologynews/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont
  • /fedprac/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase-risk
  • /oncologypractice/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont
  • /fedprac/avaho/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase
  • /jcomjournal/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase
  • /hematology-oncology/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont
  • /dermatology/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase
  • /chestphysician/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase
  • /icymi-covid/article/226652/patient-survivor-care/study-immune-checkpoint-inhibitors-dont-increase